Related Experiment Videos
Endocrinopathies associated with recurrent pregnancy loss
1Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia 30308, USA.
Seminars in Reproductive Medicine
|May 18, 2001
Summary
Recurrent pregnancy loss evaluation guidelines focus on endocrinopathies. Addressing thyroid disorders, diabetes mellitus, and luteal phase defects can improve outcomes for women experiencing repeated pregnancy wastage.
Area of Science:
- Reproductive Endocrinology
- Obstetrics & Gynecology
Background:
- Recurrent pregnancy loss (RPL) affects many women, impacting reproductive health.
- Endocrinopathies are increasingly recognized as contributing factors to RPL.
Purpose of the Study:
- To provide guidelines for evaluating endocrinopathies in patients with recurrent abortions.
- To highlight key endocrine disorders associated with recurrent pregnancy loss.
Main Methods:
- Review of current literature on endocrinopathies and recurrent pregnancy loss.
- Guidelines for diagnostic evaluation of thyroid disorders, diabetes mellitus, and luteal phase defects.
- Consideration of hyperprolactinemia and its management.
Main Results:
- Thyroid antibodies may be linked to pregnancy loss, even with normal thyroid function.
- Effective management of diabetes mellitus is crucial.
- Luteal phase defects can be treated with clomiphene citrate or progesterone.
Conclusions:
- Comprehensive endocrine evaluation is essential for managing recurrent pregnancy loss.
- Treatment of identified endocrinopathies can improve pregnancy outcomes.
- Psychological support for affected couples is an integral part of management.